A Household Study on the Prevalence of Substance Misuse in Tehran: The need for other methods to estimate the prevalence
AbstractObjective: Substance misuse is a major public health threat in Iran. The total number of addicts in Iran is estimated to be between 700,000 and 4,000,000. A few limited household studies on the prevalence of substance misuse have been performed in Iran.
Method: The residents of the sixth district of the municipality of Tehran who were over the age of 15 were selected as the study population. The sample size was 2,705. The instrument of the study was face-to-face interviews.
Results: 184(6.8%) of the subjects had used at least one substance in their lives and 142(5.2%) used a substance during the month before the interviews. 132(4.88%), 10(0.37%), 3(0.11%), 5(0.19%) and 4(15%) of the subjects reported the use of alcohol, opium, opium residue, heroin, and cannabis respectively during the month before the interviews.
Conclusion: The estimate and profile of substance use are different from other methodologies. This household study indicated lower than expected prevalence of opioids and higher than expected alcohol use. Indirect estimation methods are probably more appropriate for the prevalence studies of substance misuse in Iran.
Razzaghi EM, Rahimi Movaghar A, Hosseini M. A Rapid Situation Assessment of Drug abuse in Iran, Tehran. UNDCP; 1999.
Iranian Ministry of Health and Medical Education. The report of epidemiology of substance abuse in Islamic Republic of Iran; 2003.
Bayanzadeh A, Bolhari J, Shahmohammadi D, Nasr M, Atef vahid MK, Dadfar M. Preliminary study on the prevalence of substance abuse in rural areas of the west of Tehran province using key persons, Final report. Mental health research centre; 2002.
Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iranian Med 2002; 5: 184– 190.
Majidpour A, Kheir Khah M. [Evaluation of substance abuse prevalence in Ardabil in 1999]. JAUMS 2001; 1: 22-28.
Mohan D, Sharma NK, Sundaram KR. Patterns and prevalence of opium use in rural Punjab (India). Bull Narc 1979; 31: 45-56.
Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, Lewis G, et al. Nicotine, alcohol and drug dependence, and psychiatriccomorbidity--results of a national household survey. Int Rev Psychiatry 2003; 15: 50-56.
Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co- occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313-321.
Grant BF, Stinson FS, Dawson DA, Chou SP , Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61: 807-816.
Ramsay M, Percy A. A national household survey of drug misuse in Britain: a decade of development. Addiction 1997; 92: 931-937.
Lawrie SM, Mclntosh AM, eds. Critical Appraisal for psychiatry. Edinburgh: Churchill Livingstone; 2000.
Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev 2004; 13: 1068-1070.
Colon HM, Robles RR, Sahai H. The validity of drug use responses in a household survey in Puerto Rico: comparison of survey responses of cocaine and heroin use with hair tests. Int J Epidemiol 2001; 30: 1042-1049.
UNODC. Global Assessment Program on Drug Abuse (GAP) Toolkit Module 2. In: Taylor C, Hickman M, eds. Estimating Prevalence: Indirect Methods for Estimating the Size of the Drug Problem. Vienna, New York, United Nations: UNODC; 2003.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.